1st Quarter - Report — AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN (2010)

Firm

AMERICAN CLINICAL LABORATORY ASSN

Client

AMERICAN CLINICAL LABORATORY ASSN

Income

—

Expenses

$168,000

Expense method

C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Actions governing coding, coverage, and payment for laboratory tests; oversight of genetic testing; POD or condo laboratories; HR 3200, America's Affordable Health Choices Act; S 1796, America's Health Future Act of 2009; HR 3962, Affordable Health Care for America Act; HR 3590, Patient Protection and Affordable Care Act; HR 1699/S 1220, The Patient Access to Critical Lab Tests Act; HR 3590, Patient Protection and Affordable Care Act

Lobbyist	Covered position, as disclosed
JASON DUBOIS	Vice President, Government Relations
JO ANNE GLISSON	Senior Vice President
CHARLENE MACDONALD New	Vice President, Government Relations
ALAN MERTZ	President
DAVID ALAN MONGILLO	Vice President, Policy and Medical Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3590 (111th), H.R. 3962 (111th), H.R. 3200 (111th), H.R. 1699 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.